Literature DB >> 25848843

Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.

Takeshi Mimura1, Natalie Walker1, Yoshiro Aoki1, Casey M Manning1, Benjamin J Murdock1, Jeffery L Myers2, Amir Lagstein2, John J Osterholzer1, Vibha N Lama3.   

Abstract

Bronchiolitis obliterans is the leading cause of chronic graft failure and long-term mortality in lung transplant recipients. Here, we used a novel murine model to characterize allograft fibrogenesis within a whole-lung microenvironment. Unilateral left lung transplantation was performed in mice across varying degrees of major histocompatibility complex mismatch combinations. B6D2F1/J (a cross between C57BL/6J and DBA/2J) (Haplotype H2b/d) lungs transplanted into DBA/2J (H2d) recipients were identified to show histopathology for bronchiolitis obliterans in all allogeneic grafts. Time course analysis showed an evolution from immune cell infiltration of the bronchioles and vessels at day 14, consistent with acute rejection and lymphocytic bronchitis, to subepithelial and intraluminal fibrotic lesions of bronchiolitis obliterans by day 28. Allografts at day 28 showed a significantly higher hydroxyproline content than the isografts (33.21 ± 1.89 versus 22.36 ± 2.33 μg/mL). At day 40 the hydroxyproline content had increased further (48.91 ± 7.09 μg/mL). Flow cytometric analysis was used to investigate the origin of mesenchymal cells in fibrotic allografts. Collagen I-positive cells (89.43% ± 6.53%) in day 28 allografts were H2Db positive, showing their donor origin. This novel murine model shows consistent and reproducible allograft fibrogenesis in the context of single-lung transplantation and represents a major step forward in investigating mechanisms of chronic graft failure.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25848843      PMCID: PMC4450312          DOI: 10.1016/j.ajpath.2015.03.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  57 in total

1.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.

Authors:  Mathangi Srinivasan; Ryan Flynn; Andrew Price; Ann Ranger; Jeffrey L Browning; Patricia A Taylor; Jerome Ritz; Joseph H Antin; William J Murphy; Leo Luznik; Mark J Shlomchik; Angela Panoskaltsis-Mortari; Bruce R Blazar
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.

Authors:  Vasiliy V Polosukhin; Justin M Cates; William E Lawson; Rinat Zaynagetdinov; Aaron P Milstone; Pierre P Massion; Sebahat Ocak; Lorraine B Ware; Jae Woo Lee; Russell P Bowler; Alexey V Kononov; Scott H Randell; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

3.  Recipient cells form the proliferative lesion in the rat heterotopic tracheal allograft model of obliterative airway disease.

Authors:  Julie L Jordan; Cheryl L Hurley; Timothy D G Lee; Gregory M Hirsch
Journal:  J Heart Lung Transplant       Date:  2003-03       Impact factor: 10.247

4.  The significance of a single episode of minimal acute rejection after lung transplantation.

Authors:  Ramsey R Hachem; Anthony P Khalifah; Murali M Chakinala; Roger D Yusen; Aviva A Aloush; Thalachallour Mohanakumar; G Alexander Patterson; Elbert P Trulock; Michael J Walter
Journal:  Transplantation       Date:  2005-11-27       Impact factor: 4.939

5.  Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans.

Authors:  John J Osterholzer; Jami E Milam; Gwo-Hsiao Chen; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

6.  Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation.

Authors:  L Fan; H L Benson; R Vittal; E A Mickler; R Presson; A Jo Fisher; O W Cummings; K M Heidler; M R Keller; W J Burlingham; D S Wilkes
Journal:  Am J Transplant       Date:  2011-04-19       Impact factor: 8.086

7.  Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

Authors:  D Heng; L D Sharples; K McNeil; S Stewart; T Wreghitt; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1998-12       Impact factor: 10.247

8.  Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation.

Authors:  F L Kelly; V E Kennedy; R Jain; N S Sindhwani; C A Finlen Copeland; L D Snyder; J P Eu; E B Meltzer; B L Brockway; E Pavlisko; B R Stripp; S M Palmer
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

9.  Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology.

Authors:  Alexander S Krupnick; Xue Lin; Wenjun Li; Mikio Okazaki; Jiaming Lai; Seiichiro Sugimoto; Steven B Richardson; Christopher G Kornfeld; Joel R Garbow; G Alexander Patterson; Andrew E Gelman; Daniel Kreisel
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury.

Authors:  John J Osterholzer; Michal A Olszewski; Benjamin J Murdock; Gwo-Hsiao Chen; John R Erb-Downward; Natalya Subbotina; Keely Browning; Yujing Lin; Roger E Morey; Jeremy K Dayrit; Jeffrey C Horowitz; Richard H Simon; Thomas H Sisson
Journal:  J Immunol       Date:  2013-03-06       Impact factor: 5.422

View more
  11 in total

1.  Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction.

Authors:  Ram P Naikawadi; Gary Green; Kirk D Jones; Natalia Achtar-Zadeh; Julia E Mieleszko; Isabel Arnould; Jasleen Kukreja; John R Greenland; Paul J Wolters
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

Review 2.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

3.  Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.

Authors:  Michael P Combs; Meng Xia; David S Wheeler; Elizabeth A Belloli; Natalie M Walker; Russell R Braeuer; Dennis M Lyu; Susan Murray; Vibha N Lama
Journal:  J Heart Lung Transplant       Date:  2020-04-19       Impact factor: 10.247

Review 4.  Chronic lung allograft dysfunction phenotypes and treatment.

Authors:  Stijn E Verleden; Robin Vos; Bart M Vanaudenaerde; Geert M Verleden
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

5.  Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis.

Authors:  Pengxiu Cao; Yoshiro Aoki; Linda Badri; Natalie M Walker; Casey M Manning; Amir Lagstein; Eric R Fearon; Vibha N Lama
Journal:  J Clin Invest       Date:  2017-02-27       Impact factor: 14.808

Review 6.  Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.

Authors:  Jason M Gauthier; Daniel Ruiz-Pérez; Wenjun Li; Ramsey R Hachem; Varun Puri; Andrew E Gelman; Daniel Kreisel
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

7.  Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation.

Authors:  Natalia F Smirnova; Thomas M Conlon; Carmela Morrone; Peter Dorfmuller; Marc Humbert; Georgios T Stathopoulos; Stephan Umkehrer; Franz Pfeiffer; Ali Ö Yildirim; Oliver Eickelberg
Journal:  JCI Insight       Date:  2019-02-07

8.  Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.

Authors:  Mitsuteru Yoshida; Hisashi Oishi; Tereza Martinu; David M Hwang; Hiromitsu Takizawa; Junichi Sugihara; Trevor D McKee; Xiaohui Bai; Zehong Guana; Christina Lua; Hae-Ra Cho; Stephen Juvet; Marcelo Cypel; Shaf Keshavjee; Mingyao Liu
Journal:  Oncotarget       Date:  2018-01-03

9.  Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.

Authors:  Keizo Misumi; David S Wheeler; Yoshiro Aoki; Michael P Combs; Russell R Braeuer; Ryuji Higashikubo; Wenjun Li; Daniel Kreisel; Ragini Vittal; Jeffrey Myers; Amir Lagstein; Natalie M Walker; Carol F Farver; Vibha N Lama
Journal:  JCI Insight       Date:  2020-12-03

10.  Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosis.

Authors:  David S Wheeler; Keizo Misumi; Natalie M Walker; Ragini Vittal; Michael P Combs; Yoshiro Aoki; Russell R Braeuer; Vibha N Lama
Journal:  Am J Transplant       Date:  2021-01-04       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.